PARIS — In a move to bolster its skin health activity, Nestlé said it is acquiring the rights to commercialize the aesthetic dermatology products Restylane, Perlane, Emervel, Dysport and Sculptra in the U.S. and Canada from Valeant Pharmaceuticals International for $1.4 billion in cash.
Nestlé said the U.S. and Canada together represent more than 50 percent of the global medical aesthetics market.
"I think that all anyone really wants in life is to have people understand us for who we actually are, despite everything," says Ruth Negga. The actress talks "Preachers" season 2 and more on WWD.com. #wwdeye (📷: Dan Doperalski)
"That's something that resonates with me too because I'm so locked into a number. If I go over that number it completely ruins my day so it's nice to get detached from the number on the scale." - Chelsea Handler on Kelly LeVeque's book "Body Love." #wwdeye (📷: John Salangsang)